About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 389 record(s)
Req # A-2021-001057
Adverse Drug Reactions (ADRs) for IRBESARTAN. Report numbers: 000929982, 000946455, E2B_03587630, E2B_03567030, E2B_03587638.Organization: Health Canada
December 2021
Req # A-2021-001058
Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report number: E2B_03518325.Organization: Health Canada
December 2021
Req # A-2021-001102
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-114800-669, Letter to the COVID-19 Exposure Notification App Advisory Council Members.Organization: Health Canada
December 2021
Req # A-2021-001104
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115452-86, Deputy Ministers’ Cyber Security Committee.Organization: Health Canada
December 2021
Req # A-2021-001134
Adverse Drug Reaction (ADR) for RANITIDINE. Report number: 946117.Organization: Health Canada
December 2021
Req # A-2021-001162
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_03879484.Organization: Health Canada
December 2021
Req # A-2021-001227
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04073816, E2B_02887421.Organization: Health Canada
December 2021
Req # A-2021-001262
Adverse Drug Reaction (ADR) for HYDROCORTISONE ACETATE. Report number: 000948912.Organization: Health Canada
December 2021
Req # A-2021-001281
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106792-759.Organization: Health Canada
December 2021
Req # A-2021-001320
Adverse Drug Reaction (ADR) for BIKTARVY. Report number: 000954790.Organization: Health Canada
December 2021